Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Tickers
CRSP
EDIT
NTLA
Tags
EDIT
Stocks to Buy
Market News
From
InvestorPlace
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
Market News
NTLA
From
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Tickers
CRSP
EDIT
GNOM
ILMN
Tags
MYGN
Market News
NTRA
From
InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
June 26, 2024
Tickers
CRSP
EDIT
NLTA
Tags
CRSP
Market News
NLTA
From
InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
June 25, 2024
Tickers
CRSP
EDIT
NTLA
Tags
Market News
NTLA
NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA
From
InvestorPlace
Unveiling 5 Analyst Insights On Editas Medicine
June 18, 2024
Tickers
EDIT
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
May 30, 2024
Tickers
EDIT
Tags
Analyst Ratings
EDIT
BZI/AAR
From
Benzinga
Overlooked and Undervalued: 3 Stocks With Jaw-Dropping Upside Potential
May 30, 2024
Tickers
CNXC
EDIT
Z
Tags
NASDAQ:Z,NASDAQ:EDIT,NASDAQ:CNXC
EDIT
Z
From
InvestorPlace
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
May 09, 2024
Tickers
C
EDIT
Tags
C
EDIT
Recent Press Releases
From
Motley Fool
EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Tickers
EDIT
Tags
Market News
Earnings Reports
NASDAQ:EDIT
From
InvestorPlace
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
March 07, 2024
Tickers
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
1 Beaten-Down Stock With 55% Upside, According to Wall Street
March 04, 2024
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
March 02, 2024
Tickers
C
EDIT
VRTX
Tags
C
EDIT
VRTX
From
Motley Fool
The Latest Analyst Ratings For Editas Medicine
February 29, 2024
Tickers
EDIT
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Tickers
AAP
ACMR
ADIL
ADT
Tags
Mid/Day Movers
RXRX
Penny Stocks
From
Benzinga
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
February 28, 2024
Tickers
AAP
ACMR
ADT
ADY
Tags
RVLV
Benzinga
FLYW
From
Benzinga
Earnings Outlook For Editas Medicine
February 27, 2024
Tickers
EDIT
Tags
BZI/EP
EDIT
Benzinga
From
Benzinga
2 Under-the-Radar Stocks With Incredible Upside Potential
January 28, 2024
Tickers
EDIT
RXRX
Tags
EDIT
RXRX
Recent Press Releases
From
Motley Fool
Could Editas Medicine Become the Next CRISPR Therapeutics?
January 21, 2024
Tickers
CRSP
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Tickers
ASXC
EDIT
HOLX
ILMN
Tags
HOLX
NASDAQ:ILMN,NASDAQ:HOLX,NASDAQ:HOLX,NASDAQ:MRNA,NASDAQ:EDIT,NASDAQ:VERV,NYSEAMERICAN:ASXC
ILMN
From
InvestorPlace
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
Tickers
CRSP
EDIT
VRTX
Tags
CRSP
VRTX
Market News
From
Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
Tickers
BEAM
EDIT
LLY
VERV
Tags
VRTX
LLY
Stocks to Buy
From
InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
January 08, 2024
Tickers
EDIT
NTLA
Tags
Market News
NTLA
Recent Press Releases
From
Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
December 23, 2023
Tickers
EDIT
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
December 13, 2023
Tickers
EDIT
SPX
VRTX
VTRS
Tags
VTRS
EDIT
VRTX
From
MarketWatch
The Latest Analyst Ratings for Editas Medicine
December 12, 2023
Tickers
EDIT
Tags
Analyst Ratings
EDIT
BZI/AAR
From
Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
EDIT
BLUE
VRTX
From
MarketWatch
1 Promising Stock Down 66% That Could Skyrocket in 2024
December 05, 2023
Tickers
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Tickers
ARKG
BEAM
CRBU
CRSP
Tags
CRBU
REGN
CRSP
From
Motley Fool
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
November 29, 2023
Tickers
BLUE
EDIT
GPCR
Tags
GPCR
Market News
BLUE
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.